REBISTART: Adherence of Patients with Multiple Sclerosis to Treatment with Subcutaneous Interferon Beta in the Context of a Patient Support Program

ConclusionsVery high adherence rates independent of the PSP nursing service over 1  year of treatment indicate that IFN beta-1a sc is an easy-to-use and well-tolerated disease-modifying drug.Trial Registration NumberVfa.de: No. 892.https://www.vfa.de/de/arzneimittel-forschung/datenbanken-zu-arzneimitteln/nisdb/nis-details/_892.
Source: Neurology and Therapy - Category: Neurology Source Type: research